Living with HIV means managing a long-term journey with the immune system. While antiretroviral therapy helps many people stay healthy, the body still faces the challenge of aging. Researchers have identified several markers that can help track this process, including the CD4/CD8 ratio and specific T-cell markers like CD28 and CD57.
These markers, along with others like PD-1 expression and inflammatory cytokine panels, provide a clearer picture of how the immune system changes over time. The study also suggests a link between these signs of aging and the characteristics of the HIV reservoir, which is the part of the body where the virus hides.
While these findings are promising, there is still work to do. Because of factors like genetic diversity and different viral types, these markers need more testing in specific regions like sub-Saharan Africa. These tools could eventually help doctors better monitor health and plan for new ways to treat the virus.
Common questions
What are the markers for immune aging in HIV patients?
Several markers show promise for tracking immune aging. These include the CD4/CD8 ratio, T-cell senescence markers (CD28 and CD57+ expression), PD-1 expression, and specific inflammatory cytokine panels. These markers help doctors see how the immune system changes during long-term antiretroviral therapy.
Is there a link between immune aging and the HIV reservoir?
Evidence suggests that immune aging is associated with the characteristics of the HIV reservoir. The reservoir is the part of the body where the virus remains. Understanding this link helps researchers study how the immune system functions while a person is on long-term treatment.
Are these markers fully proven for everyone?
Not yet. The review notes that the validation of these markers is incomplete in some populations, particularly in sub-Saharan Africa. Factors like genetic diversity, different viral subtypes, and other infections mean more research is needed to confirm these markers for everyone.
